KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
15,510
+240 (1.57%)
Last updated: Jun 16, 2025
KOREA PHARMA Revenue
KOREA PHARMA had revenue of 20.79B KRW in the quarter ending March 31, 2025, with 2.49% growth. This brings the company's revenue in the last twelve months to 81.78B, down -1.63% year-over-year. In the year 2024, KOREA PHARMA had annual revenue of 81.28B, down -2.36%.
Revenue (ttm)
81.78B
Revenue Growth
-1.63%
P/S Ratio
2.06
Revenue / Employee
610.32M
Employees
134
Market Cap
168.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81.28B | -1.96B | -2.36% |
Dec 31, 2023 | 83.24B | 2.21B | 2.73% |
Dec 31, 2022 | 81.03B | 1.45B | 1.83% |
Dec 31, 2021 | 79.58B | 8.07B | 11.28% |
Dec 31, 2020 | 71.51B | 5.37B | 8.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
Kia Corporation | 109.25T |